Savran Technologies to Target Breast Cancer Recurrence with Circulating Tumor Cell Platform
The startup aims to combine its microfluidic platform with a circulating tumor DNA-based assay offered by a potential partner and launch the test by 2022.
Purdue University Developing Classifier to Better Predict Cancer Patients' Responses to Chemo
Their machine learning technology coupled with digital holography produced an 84 percent success rate in predicting canine responses to chemotherapy.
Purdue University Scientists Devise Paper-Based Microfluidic for Potential POC Use
By pressing on a piece of paper, a user could power up the test and potentially apply it in a remote location, the researchers said.
Purdue University System Could Eliminate Blood Draw in Some Clinical Tests
The researchers said that they are developing a fiber probe that could generate a Bessel beam that could be inserted into arteries to obtain internal images.
The method uses graphene-coated silica particles fused to complementary RNA to register impedance changes in the presence of viruses.